Published Date: 02 Mar 2023
The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.
Read Full NewsResearchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.
A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.
1.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
2.
Adult overdose deaths on the rise
3.
Bayer is transforming pharmaceutical research into women's health
4.
A Century of Schizophrenia: One Disorder or Many?
5.
Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.
1.
The Unseen Danger of Anal Cancer: How to Protect Yourself
2.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
3.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
4.
The Importance of Corrected Calcium Levels in Managing Health Conditions
5.
Tumor Dormancy and Cancer Recurrence: Mechanisms, Clinical Implications, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation